Erick Wayne DeVinney - 15 Feb 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
VP Peripheral Nerve Science
Signature
/s/Erick DeVinney
Issuer symbol
AXGN
Transactions as of
15 Feb 2022
Net transactions value
-$3,006
Form type
4
Filing time
17 Feb 2022, 15:05:31 UTC
Previous filing
29 Dec 2021
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Award $0 +1,181 +1.4% $0.000000 88,432 15 Feb 2022 Direct F1, F2
transaction AXGN Common Stock Tax liability $3,006 -357 -0.4% $8.42 88,075 15 Feb 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria.
F2 Includes 2 shares acquired under the Axogen stock purchase plan on December 31, 2021.
F3 The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022.